TargetBile acid receptor(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Antagonist activity at human FXR expressed in CV-1 cells assessed as inhibition of CDCA-induced receptor transactivation after 24 hrs by luciferase r...More data for this Ligand-Target Pair
TargetBile acid receptor(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 5.00E+3nMAssay Description:Antagonist activity at human FXR expressed in CV-1 cells assessed as inhibition of CDCA-induced receptor transactivation after 24 hrs by luciferase r...More data for this Ligand-Target Pair
TargetBile acid receptor(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 6.00E+3nMAssay Description:Antagonist activity at human FXR expressed in CV-1 cells assessed as inhibition of CDCA-induced receptor transactivation after 24 hrs by luciferase r...More data for this Ligand-Target Pair
TargetBile acid receptor(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 4.10E+4nMAssay Description:Antagonist activity at human FXR expressed in HEK293 cells assessed as inhibition of GW4064-induced transactivation after 24 hrs by luciferase report...More data for this Ligand-Target Pair